lymphocyte antigen cd20 epitope peptide fragment bound rituximab fab indications for include leukemia

navigate by keyword : pdb2osl cd20 cluster differentiation blymphocyte lymphocyte bcell antigen ms4a1 surface lymphoma leukemia immunohistochemistry histology antibody rituximab fab epitope autoimmune cancer rheumatoid arthritis purpura thrombocytopenic pemphigus vulgaris monoclonal structure peptide protein amino acid molecule polypeptide polymer atoms science scientific disease health molecular model rendering illustration white background

B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia Royalty Free Stock Photo
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia Royalty Free Stock Photo
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia Royalty Free Stock Photo
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia Royalty Free Stock Photo
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia Royalty Free Stock Photo
   
   
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia Royalty Free Stock Photo
   
   
   
   
   
   
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia, lymphoma and rheumatoid arthritis. 3D rendering based on protein data bank entry 2osl. Atoms shown as color-coded spheres. Per chain coloring

Stockphotos.ro (c) 2025. All stock photos are provided by Dreamstime and are copyrighted by their respective owners.